Your browser doesn't support javascript.
loading
Clinical efficacy and safety of synthetic thymic peptides with chemotherapy for non-small cell lung cancer in China: A systematic review and meta-analysis of 27 randomized controlled trials following the PRISMA guidelines.
Zeng, Fen-Lian; Xiao, Zheng; Wang, Cheng-Qiong; Jiang, Yuan; Shan, Jing-Li; Hu, Shan-Shan; Huang, Xiao-Rong; Tang, Yu-Hong; Yao, Xing-Sheng; Zhang, Tao; Zeng, Xian-Tao; Feng, Ji-Hong; Xiao, Xue.
Afiliação
  • Zeng FL; Department of General Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi 563003, Guizhou, China; Department of Clinical Nursing, Affiliated Hospital of Zunyi Medical University, Zunyi 563003, Guizhou, China.
  • Xiao Z; Department of General Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi 563003, Guizhou, China; Evidence-Based Medicine Center, MOE Virtual Research Center of Evidence-based Medicine at Zunyi Medical University, Affiliated Hospital of Zunyi Medical University, Zunyi 563003, Guizhou, C
  • Wang CQ; Department of General Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi 563003, Guizhou, China; Evidence-Based Medicine Center, MOE Virtual Research Center of Evidence-based Medicine at Zunyi Medical University, Affiliated Hospital of Zunyi Medical University, Zunyi 563003, Guizhou, C
  • Jiang Y; Evidence-Based Medicine Center, MOE Virtual Research Center of Evidence-based Medicine at Zunyi Medical University, Affiliated Hospital of Zunyi Medical University, Zunyi 563003, Guizhou, China; School of Management, Zunyi Medical University, Zunyi 563003, Guizhou, China.
  • Shan JL; Department of General Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi 563003, Guizhou, China; Evidence-Based Medicine Center, MOE Virtual Research Center of Evidence-based Medicine at Zunyi Medical University, Affiliated Hospital of Zunyi Medical University, Zunyi 563003, Guizhou, C
  • Hu SS; GCP Center, Affiliated Hospital of Zunyi Medical University, Zunyi 563003, Guizhou, China.
  • Huang XR; GCP Center, Affiliated Hospital of Zunyi Medical University, Zunyi 563003, Guizhou, China.
  • Tang YH; School of Management, Zunyi Medical University, Zunyi 563003, Guizhou, China.
  • Yao XS; Department of Immunology, Special Key Laboratory of Gene Detection & Therapy of Guizhou Province, Zunyi Medical University, Zunyi 563000, Guizhou, China.
  • Zhang T; Key Laboratory of Cell Engineering of Guizhou Province and Regenerative Medicine Centre, Affiliated Hospital of Zunyi Medical University, Zunyi 519000, Guizhou, China.
  • Zeng XT; Center for Evidence-based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, Hubei, China.
  • Feng JH; Department of Oncology, Medical College of Taizhou University Affiliated Taizhou Municipal Hospital, Taizhou 318000, Zhejiang, China.
  • Xiao X; Department of General Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi 563003, Guizhou, China; Evidence-Based Medicine Center, MOE Virtual Research Center of Evidence-based Medicine at Zunyi Medical University, Affiliated Hospital of Zunyi Medical University, Zunyi 563003, Guizhou, C
Int Immunopharmacol ; 75: 105747, 2019 Oct.
Article em En | MEDLINE | ID: mdl-31326719
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline / Systematic_reviews Limite: Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline / Systematic_reviews Limite: Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2019 Tipo de documento: Article